Please login to the form below

Not currently logged in
Email:
Password:

Parkinson's UK

This page shows the latest Parkinson's UK news and features for those working in and with pharma, biotech and healthcare.

Axovant drops last ‘legacy’ drug to focus on gene therapies

Axovant drops last ‘legacy’ drug to focus on gene therapies

s original business model of licensing dormant drugs from other developers and re-purposing them for new uses. ... licensed rights to a gene therapy for Parkinson’s disease (PD) from UK biotech Oxford BioMedica for $30m upfront.

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Parkinson's UK appoints Arthur Roach as research director Parkinson's UK appoints Arthur Roach as research director

    Parkinson's UK has appointed Dr Arthur Roach as its research director to help it build on a string of recent successes. ... do.". "Parkinson's UK is in a unique position to ignite collaboration between researchers, companies, doctors and people with

  • Publicis Life Brands Resolute hires Simon Goldsborough Publicis Life Brands Resolute hires Simon Goldsborough

    Simon's background, experience and skills will be a great addition and complement our existing team,” said Anna Korving, managing director. ... Goldsborough has also served at PR firms Third Sector PR and Grayling, and in media relations roles at the

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • The power of the patient

    Matt has also had several articles published, most notably in Parkinson's Europe and Primary Care Today. ... He has also written a series of articles for Parkinson's UK in their Quarterly Journal.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics